These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 14974845)
1. Laboratory diagnosis of canine GM2-gangliosidosis using blood and cerebrospinal fluid. Yamato O; Satoh H; Matsuki N; Ono K; Yamasaki M; Maede Y J Vet Diagn Invest; 2004 Jan; 16(1):39-44. PubMed ID: 14974845 [TBL] [Abstract][Full Text] [Related]
2. Canine GM2-Gangliosidosis Sandhoff Disease Associated with a 3-Base Pair Deletion in the HEXB Gene. Wang P; Henthorn PS; Galban E; Lin G; Takedai T; Casal M J Vet Intern Med; 2018 Jan; 32(1):340-347. PubMed ID: 29106755 [TBL] [Abstract][Full Text] [Related]
3. Increased concentration of GM1-ganglioside in cerebrospinal fluid in dogs with GM1- and GM2-gangliosidoses and its clinical application for diagnosis. Satoh H; Yamato O; Asano T; Yamasaki M; Maede Y J Vet Diagn Invest; 2004 May; 16(3):223-6. PubMed ID: 15152837 [TBL] [Abstract][Full Text] [Related]
4. Thermodynamic determination of plasma and leukocyte beta-hexosaminidase isoenzymes in homozygote and heterozygote carriers for the GM2 gangliosidosis B1 variant. Casal JA; Pérez LF; Tutor JC Am J Clin Pathol; 2003 May; 119(5):684-8. PubMed ID: 12760286 [TBL] [Abstract][Full Text] [Related]
5. Partial deficiency of beta-hexosaminidase activity in canine GM2-gangliosidosis. Eto Y; Ida H; Umezawa F; Ohashi T; Gomibuchi I; Maekawa K Tohoku J Exp Med; 1987 Aug; 152(4):333-8. PubMed ID: 2958961 [TBL] [Abstract][Full Text] [Related]
6. Inefficiency in GM2 ganglioside elimination by human lysosomal beta-hexosaminidase beta-subunit gene transfer to fibroblastic cell line derived from Sandhoff disease model mice. Itakura T; Kuroki A; Ishibashi Y; Tsuji D; Kawashita E; Higashine Y; Sakuraba H; Yamanaka S; Itoh K Biol Pharm Bull; 2006 Aug; 29(8):1564-9. PubMed ID: 16880605 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of 4-methylumbelliferyl-6-sulfo-2-acetamido-2-deoxy-beta-D-glucopyrano sid e for the diagnosis of GM2 gangliosidoses in leukocytes. Inui K; Wenger DA Clin Genet; 1984 Oct; 26(4):318-21. PubMed ID: 6238730 [TBL] [Abstract][Full Text] [Related]
9. Biochemical basis of type AB GM2 gangliosidosis in a Japanese spaniel. Ishikawa Y; Li SC; Wood PA; Li YT J Neurochem; 1987 Mar; 48(3):860-4. PubMed ID: 2949061 [TBL] [Abstract][Full Text] [Related]
10. Biochemical characterization of the GM2 gangliosidosis B1 variant. Tutor JC Braz J Med Biol Res; 2004 Jun; 37(6):777-83. PubMed ID: 15264019 [TBL] [Abstract][Full Text] [Related]
11. Specificity of mouse GM2 activator protein and beta-N-acetylhexosaminidases A and B. Similarities and differences with their human counterparts in the catabolism of GM2. Yuziuk JA; Bertoni C; Beccari T; Orlacchio A; Wu YY; Li SC; Li YT J Biol Chem; 1998 Jan; 273(1):66-72. PubMed ID: 9417048 [TBL] [Abstract][Full Text] [Related]
12. GM2-ganglioside metabolism in hexosaminidase A deficiency states: determination in situ using labeled GM2 added to fibroblast cultures. Raghavan SS; Krusell A; Krusell J; Lyerla TA; Kolodny EH Am J Hum Genet; 1985 Nov; 37(6):1071-82. PubMed ID: 2934978 [TBL] [Abstract][Full Text] [Related]
13. A Pro504 --> Ser substitution in the beta-subunit of beta-hexosaminidase A inhibits alpha-subunit hydrolysis of GM2 ganglioside, resulting in chronic Sandhoff disease. Hou Y; McInnes B; Hinek A; Karpati G; Mahuran D J Biol Chem; 1998 Aug; 273(33):21386-92. PubMed ID: 9694901 [TBL] [Abstract][Full Text] [Related]
14. GM2 gangliosidosis variant 0 (Sandhoff-like disease) in a family of toy poodles. Tamura S; Tamura Y; Uchida K; Nibe K; Nakaichi M; Hossain MA; Chang HS; Rahman MM; Yabuki A; Yamato O J Vet Intern Med; 2010; 24(5):1013-9. PubMed ID: 20695991 [TBL] [Abstract][Full Text] [Related]
15. GM2 gangliosidosis associated with a HEXA missense mutation in Japanese Chin dogs: a potential model for Tay Sachs disease. Sanders DN; Zeng R; Wenger DA; Johnson GS; Johnson GC; Decker JE; Katz ML; Platt SR; O'Brien DP Mol Genet Metab; 2013 Jan; 108(1):70-5. PubMed ID: 23266199 [TBL] [Abstract][Full Text] [Related]
16. Distribution of enzyme-bearing cells in GM2 gangliosidosis mice: regionally specific pattern of cellular infiltration following bone marrow transplantation. Oya Y; Proia RL; Norflus F; Tifft CJ; Langaman C; Suzuki K Acta Neuropathol; 2000 Feb; 99(2):161-8. PubMed ID: 10672323 [TBL] [Abstract][Full Text] [Related]
17. Variant of GM2-gangliosidosis with hexosaminidase A having a severely changed substrate specificity. Kytzia HJ; Hinrichs U; Maire I; Suzuki K; Sandhoff K EMBO J; 1983; 2(7):1201-5. PubMed ID: 6226523 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies. Tsuji D; Higashine Y; Matsuoka K; Sakuraba H; Itoh K Clin Chim Acta; 2007 Mar; 378(1-2):38-41. PubMed ID: 17196574 [TBL] [Abstract][Full Text] [Related]
19. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases. Huang JQ; Trasler JM; Igdoura S; Michaud J; Hanal N; Gravel RA Hum Mol Genet; 1997 Oct; 6(11):1879-85. PubMed ID: 9302266 [TBL] [Abstract][Full Text] [Related]
20. Validity of lymphoid cell line for enzymatic studies of GM2-gangliosidosis variant 0 (Sandhoff disease). Maret A; Salvayre R; Radon J; Hardy M; Vuillaume M; Lenoir G; Douste-Blazy L Enzyme; 1985; 34(1):48-56. PubMed ID: 3002784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]